Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.

Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.

Item
http://www.wikidata.org/entity/Q32068652
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia.Plasma levels of procalcitonin and eight additional inflammatory molecules in febrile neutropenic patients.Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients.Sedimentation characteristics of leucocytes can predict bacteraemia in critical care patients.Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock.Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.Endothelial cells are main producers of interleukin 8 through Toll-like receptor 2 and 4 signaling during bacterial infection in leukopenic cancer patients.Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?The role of oral mucositis on the systemic inflammation parameter IL-8 in febrile neutropenic cancer patients.Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia.Inflammatory cytokine measurement quickly discriminates gram-negative from gram-positive bacteremia in pediatric hematology/oncology patients with septic shock.
P2860

Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.

Item
http://www.wikidata.org/entity/Q32068652
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Prediction of gram-negative ba ...... py versus combination therapy.
@ast
Prediction of gram-negative ba ...... py versus combination therapy.
@en
type
label
Prediction of gram-negative ba ...... py versus combination therapy.
@ast
Prediction of gram-negative ba ...... py versus combination therapy.
@en
prefLabel
Prediction of gram-negative ba ...... py versus combination therapy.
@ast
Prediction of gram-negative ba ...... py versus combination therapy.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Prediction of gram-negative ba ...... py versus combination therapy.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921